98%
921
2 minutes
20
Abactstr: BACKGROUND: Telemedicine has expanded healthcare accessibility, particularly during the COVID-19 pandemic. However, evidence regarding its economic efficiency and clinical quality remains inconclusive, with some studies suggesting increased costs, service utilization, and inappropriate antibiotic prescribing compared to traditional care modalities.
Objective: This study evaluated pediatric telemedicine services across three dimensions: clinical outcomes (antibiotic prescribing patterns), resource utilization implications (healthcare utilization and emergency department visits), and equity considerations (sociodemographic distribution of services).
Methods: We conducted a retrospective cohort study analysis of 1,500 children under 19 years within Israel's Clalit Health Services (Shron-Shomron District) from January 2021 to January 2022. Participants were randomly sampled from three groups based on their telemedicine utilization patterns: in-person primary care physician (PCP) visits only (n = 500); PCP plus phone/video telemedicine (n = 500); and PCP plus phone/video plus Tyto device telemedicine (n = 500). These children were classified as discrete groups, not only as solitary visits. We assessed emergency department (ED) admission rates, antibiotic prescription frequencies for common pediatric conditions, and sociodemographic characteristics across the groups.
Results: Analysis of 21,968 visits revealed striking socioeconomic disparities in telemedicine utilization. While 58.1% of all participants had high socioeconomic status (SES), this increased to 68.6% among Tyto device users. Conversely, low-SES patients comprised 26.4% of in-person-only visits but only 3% of Tyto users. ED admission rates for all groups combined were 4.0%, 1.6% for the "PCP only" group, 5.4% for the "PCP + phone/video" group (12% after phone/video visits), and 3.6% for the "PCP + phone/video + Tyto" group (4.1% after Tyto only). Antibiotic prescribing rates were similarly divergent: mean rates of antibiotic prescriptions after PCP visits were 10.3%, after telephone/video visits were 16.8%, and after Tyto visits were 21.4% (p < 0.001). Multivariable analysis confirmed those findings and demonstrated higher ED utilization and antibiotic prescribing among low-SES patients and those in remote locations, independent of visit type.
Conclusions: Our findings challenge prevailing assumptions about telemedicine benefits, revealing unexpected associations between telemedicine services and higher ED utilization and antibiotic prescribing compared to traditional care, particularly among vulnerable populations. These associations may reflect complex interactions between patient characteristics, provider behavior, and care modalities that warrant further investigation. Healthcare systems should reconsider the implementation of telemedicine services to ensure they deliver on promises of expanded access while maintaining quality, appropriate resource utilization, and equitable distribution of benefits across socioeconomic groups.
Clinical Trial Number: Not applicable.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344953 | PMC |
http://dx.doi.org/10.1186/s12911-025-03124-2 | DOI Listing |
Antimicrob Steward Healthc Epidemiol
September 2025
Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA.
Antimicrob Steward Healthc Epidemiol
September 2025
National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia.
Background: infections (CDI) increased at a large, regional hospital in New South Wales, Australia, in 2021, coinciding with an increase at hospitals Australia wide. We aimed to investigate the association between antibiotic prescribing practices and hospital-acquired CDI at the hospital to inform antimicrobial stewardship (AMS) programs.
Methods: We conducted a retrospective case-control study for the period July 1, 2018, and June 30, 2022.
Rev Cuid
July 2025
Fundación Cardiovascular de Colombia, Piedecuesta, Santander, Colombia. Postgraduate Department in Infectious Disease, Universidad de Santander, Santander, Colombia. E-mail: Fundación Cardiovascular de Colombia Santander Colombia
Introduction: The inappropriate use of antibiotics in intensive care units poses risks, such as increased infections caused by multidrug-resistant bacteria and adverse reactions. The World Health Organization's strategy, named Access, Watch, and Reserve, aims to mitigate these risks by categorizing antibiotics into these categories.
Objective: To characterize antibiotic consumption in the adult population of intensive care units during the first quarter of 2023.
Pediatr Emerg Care
September 2025
Department of Pediatrics, Children's Mercy Kansas City.
Objective: To increase the percentage of first-line antibiotics prescribed for acute otitis media (AOM) and pharyngitis, the percentage of treated pharyngitis with a positive group A streptococcus (GAS) test, and the percentage of nonsevere AOM patients prescribed delayed antibiotics in pediatric urgent care clinics (UCCs).
Methods: The American Academy of Pediatrics Section on Urgent Care Medicine and Pediatric Acute and Critical Care Quality Network developed a multicenter quality improvement collaborative. We used national guidelines to determine criteria for nonsevere AOM and first-line antibiotics for AOM and pharyngitis.
Allergol Immunopathol (Madr)
September 2025
Department of Chest Diseases, Division of Allergy and Clinical Immunology, Erciyes University School of Medicine, Kayseri, Türkiye.
Objective: The aim of this study was to evaluate whether fluoroquinolone antibiotics, which are structurally distinct from penicillins, can be safely prescribed as alternatives for patients with a history of immediate-type hypersensitivity reactions (HSRs) to penicillin in the absence of multidrug allergy and without the need for provocation testing.
Methods: We conducted a retrospective analysis of the medical records of patients who presented to the Erciyes University Adult Immunology and Allergy Outpatient Clinic with a documented history of penicillin allergy between 2015 and 2024. Inclusion criteria for immediate hypersensitivity to penicillin included at least one of the following: (1) a history of at least two separate immediate HSRs to the same penicillin; or (2) positive results from penicillin G/V (Penicillin G and Penicillin V) serum-specific immunoglobulin E (SsIgE) and/or skin prick testing.